-
Hematologica | Team Led by Jianxiang Wang Publishes Results of the Largest Domestic Prospective Cohort Study on Treating Adult Ph-negative ALL with Pediatric-inspired Regimen
Acute Lymphoblastic Leukemia (ALL) is a malignant hematologic tumor characterized by the clonal proliferation of immature lymphocytes in the bone marrow, peripheral blood, and extramedullary tissues. ALL predominantly affects children…
-
Clin Cancer Res丨Gang An/Lugui Qiu Team First in China to Confirm Mass Spectrometry Technology for Minimally Invasive Monitoring of MRD in MM Patients Through Targeted Tracking of Serum M-Protein
The study incorporated 56 newly diagnosed MM patients from the national hematologic disease longitudinal cohort-multiple myeloma sub-cohort. By conducting easyM MS testing (a mass spectrometry-based protein analysis method) on the…
-
Professor Cai-Cun Zhou: KRAS G12D Inhibitor HRS-4642 Shows Encouraging Activity in Late-Stage Solid Tumors with KRAS G12D Mutation
The 2023 European Society for Medical Oncology (ESMO) Annual Meeting took place in Madrid, Spain, from October 20th to 24th. The Tumor Insight team delved into the front lines, capturing international advancements and witnessing China’s contributions to the field of oncology on the global stage. Professor Cai-Cun Zhou from Tongji University Affiliated Shanghai Pulmonary Hospital…
-
ESMO Big Shot Interview | Professor Xu Ruihua: Oncology in China Is Thriving, with a Record Number of Selected Papers
The 2023 European Society for Medical Oncology (ESMO) Annual Congress was held in Madrid, Spain from October 20th to 24th. The Oncology Horizon team went deep into the front lines, capturing international advancements and witnessing the progress of cancer research in China on the global stage. Professor Xu Ruihua from Sun Yat-sen University Cancer Center…
-
Transforming Prostate Cancer Care: Insights from Dr. Marie-Pier St-Laurent at ASCO GU
We are thrilled to share an exclusive video featuring the esteemed Dr. Marie-Pier St-Laurent, directly from the ASCO GU conference. Dive deep into the latest breakthroughs in prostate cancer research,…
-
Advancing Prostate Cancer Treatment: Breakthroughs and Strategies with Dr. Neal D. Shore
Welcome to our in-depth Specialist Interview series. In this episode, we’re honored to have Dr. Neal D. Shore from the Carolina Urologic Research Center discuss pivotal advancements in prostate cancer…
-
“CCHIO 2023 | Professor Zhang Jin: Classification Management and Precision Treatment of Breast Cancer Patients”
Breast cancer is the most common malignancy among women globally, with an increasing incidence rate that poses a significant threat to women’s health worldwide. Molecular typing aids in the precise classification and stratified treatment of breast cancer. The continuous development of immunotherapy and targeted therapy offers new treatment options for patients with different types. At…
Connecting Medical Expertise through Media